Assessment of mTOR-Dependent translational regulation of interferon stimulated genes

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Livingstone, Mark ^a,d   Sikström, Kristina ^b   Robert, Philippe A ^a   Uzé, Gilles ^c   Larsson, Ola ^b   Pellegrini, Sandra Pellegrini ^a  

^a INSTITUT PASTEUR   (France)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITÉ DE MONTPELLIER   (France)

^d Tebu bio SAS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; TOLL LIKE RECEPTOR 3; TORIN1 PROTEIN; UNCLASSIFIED DRUG; 1-(4-(4-PROPIONYLPIPERAZIN-1-YL)-3-(TRIFLUOROMETHYL)PHENYL)-9-(QUINOLIN-3-YL)BENZO(H)(1,6)NAPHTHYRIDIN-2(1H)-ONE; NAPHTHYRIDINE DERIVATIVE; TARGET OF RAPAMYCIN KINASE;

5' UNTRANSLATED REGION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE; GENE REPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTERFERON STIMULATED GENE; NT5C3A GENE; PROTEIN SYNTHESIS INHIBITION; RNA TRANSLATION; RNF19B GENE; SIGNAL TRANSDUCTION; TLR3 GENE; TRANSCRIPTION INITIATION SITE; TRANSLATION REGULATION; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN SYNTHESIS;

CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-BETA; NAPHTHYRIDINES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; TOR SERINE-THREONINE KINASES;

EID: 84942015042     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133482     Document Type: Article

References (65)

1. Stark GR, Darnell JE Jr. (2012) The JAK-STAT pathway at twenty. Immunity 36: 503-514. doi: 10. 1016/j.immuni.2012.03.013 PMID: 22520844
2. Borden EC, Williams BR (2011) Interferon-stimulated genes and their protein products: what and how? J Interferon Cytokine Research 31: 1-4.
3. Tamura T, Yanai H, Savitsky D, Taniguchi T (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26: 535-584. doi: 10.1146/annurev.immunol.26.021607.090400 PMID: 18303999
4. Deb DK, Sassano A, Lekmine F, Majchrzak B, Verma A, Kambhampati S, et al. (2003) Activation of protein kinase C delta by IFN-gamma. J Immunol 171: 267-273. PMID: 12817007
5. Joshi S, Kaur S, Kroczynska B, Platanias LC (2010) Mechanisms of mRNA translation of interferon stimulated genes. Cytokine 52: 123-127. doi: 10.1016/j.cyto.2010.03.019 PMID: 20409730
6. Joshi S, Kaur S, Redig AJ, Goldsborough K, David K, Ueda T, et al. (2009) Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses. Proc Natl Acad Sci USA 106: 12097-12102. doi: 10.1073/pnas.0900562106 PMID: 19574459
7. Kaur S, Lal L, Sassano A, Majchrzak-Kita B, Srikanth M, Baker DP, et al. (2007) Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. J Biol Chem 282: 1757-1768. PMID: 17114181
8. Kaur S, Parmar S, Smith J, Katsoulidis E, Li Y, Sassano A, et al. (2005) Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells. Exp Hematol 33: 550-557. PMID: 15850832
9. Kaur S, Sassano A, Joseph AM, Majchrzak-Kita B, Eklund EA, Verma A, et al. (2008) Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. J Immunol 181: 7316-7323. PMID: 18981154
10. Kroczynska B, Joshi S, Eklund EA, Verma A, Kotenko SV, Fish EN, et al. (2011) Regulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNlambda signaling. J Biol Chem 286: 1147-1156. doi: 10.1074/jbc. M110.183566 PMID: 21075852
11. Kroczynska B, Kaur S, Katsoulidis E, Majchrzak-Kita B, Sassano A, Kozma SC, et al. (2009) Interferondependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals. Mol Cell Biol 29: 2865-2875. doi: 10.1128/MCB.01537-08 PMID: 19289497
12. Lekmine F, Uddin S, Sassano A, Parmar S, Brachmann SM, Majchrzak B, et al. (2003) Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J Biol Chem 278: 27772-27780. PMID: 12759354
13. Li Y, Batra S, Sassano A, Majchrzak B, Levy DE, Gaestel M, et al. (2005) Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons. J Biol Chem 280: 10001-10010. PMID: 15644321
14. Srivastava KK, Batra S, Sassano A, Li Y, Majchrzak B, Kiyokawa H, et al. (2004) Engagement of protein kinase C-theta in interferon signaling in T-cells. J Biol Chem 279: 29911-29920. PMID: 15150272
15. Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, et al. (2002) Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 277: 14408-14416. PMID: 11839738
16. Furic L, Livingstone M, Dowling RJ, Sonenberg N (2009) Targeting mTOR-dependent tumours with specific inhibitors: a model for personalized medicine based on molecular diagnoses. Curr Oncol 16: 59-61. PMID: 19229373
17. Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122: 3589-3594. doi: 10.1242/ jcs.051011 PMID: 19812304
18. Morita M, Gravel SP, Chenard V, Sikstrom K, Zheng L, Alain T, et al. (2013) mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab 18: 698-711. doi: 10.1016/j.cmet.2013.10.001 PMID: 24206664
19. Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, et al. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332: 1317-1322. doi: 10.1126/science.1199498 PMID: 21659604
20. Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Nat Acad Sci USA 95: 1432-1437. PMID: 9465032
21. Livingstone M, Bidinosti M (2012) Rapamycin-insensitive mTORC1 activity controls eIF4E:4E-BP1 binding. F1000 Research 1: 1-4. doi: 10.12688/f1000research.1-4.v1 PMID: 24358826
22. Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, et al. (2001) Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15: 2852-2864. PMID: 11691836
23. Mothe-Satney I, Yang D, Fadden P, Haystead TA, Lawrence JC Jr. (2000) Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol Cell Biol 20: 3558-3567. PMID: 10779345
24. Tait S, Dutta K, Cowburn D, Warwicker J, Doig AJ, McCarthy JE, et al. (2010) Local control of a disorder-order transition in 4E-BP1 underpins regulation of translation via eIF4E. Proc Natl Acad Sci USA 107: 17627-17632. doi: 10.1073/pnas.1008242107 PMID: 20880835
25. Tomoo K, Abiko F, Miyagawa H, Kitamura K, Ishida T (2006) Effect of N-terminal region of eIF4E and Ser65-phosphorylation of 4E-BP1 on interaction between eIF4E and 4E-BP1 fragment peptide. J Biochem 140: 237-246. PMID: 16825247
26. Tomoo K, Matsushita Y, Fujisaki H, Abiko F, Shen X, Taniguchi T, et al. (2005) Structural basis for mRNA Cap-Binding regulation of eukaryotic initiation factor 4E by 4E-binding protein, studied by spectroscopic, X-ray crystal structural, and molecular dynamics simulation methods. Biochem Biophys Acta 1753: 191-208. PMID: 16271312
27. Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, et al. (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284: 8023-8032. doi: 10.1074/jbc.M900301200 PMID: 19150980
28. Meyuhas O, Dreazen A (2009) Ribosomal protein S6 kinase from TOP mRNAs to cell size. Prog Mol Biol Transl Sci 90: 109-153. doi: 10.1016/S1877-1173(09)90003-5 PMID: 20374740
29. Miloslavski R, Cohen E, Avraham A, Iluz Y, Hayouka Z, Kasir J, et al. (2014) Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner. J Mol Cell Biol 6: 255-266. doi: 10.1093/jmcb/mju008 PMID: 24627160
30. Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, Nir T, et al. (2005) Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev 19: 2199-2211. PMID: 16166381
31. Tcherkezian J, Cargnello M, Romeo Y, Huttlin EL, Lavoie G, Gygi SP, et al. (2014) Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation. Genes Dev 28: 357-371. doi: 10.1101/gad.231407.113 PMID: 24532714
32. Genolet R, Araud T, Maillard L, Jaquier-Gubler P, Curran J (2008) An approach to analyse the specific impact of rapamycin on mRNA-ribosome association. BMC Med Genomics 1: 33. doi: 10.1186/1755-8794-1-33 PMID: 18673536
33. Grolleau A, Bowman J, Pradet-Balade B, Puravs E, Hanash S, Garcia-Sanz JA, et al. (2002) Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J Biol Chem 277: 22175-22184. PMID: 11943782
34. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. (2012) The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485: 55-61. doi: 10.1038/ nature10912 PMID: 22367541
35. Larsson O, Morita M, Topisirovic I, Alain T, Blouin MJ, Pollak M, et al. (2012) Distinct perturbation of the translatome by the antidiabetic drug metformin. Proc Natl Acad Sci USA 109: 8977-8982. doi: 10. 1073/pnas.1201689109 PMID: 22611195
36. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485: 109-113. doi: 10.1038/nature11083 PMID: 22552098
37. Eliseeva IA, Vorontsov IE, Babeyev KE, Buyanova SM, Sysoeva MA, Kondrashov F, et al. (2013) In silico motif analysis suggests an interplay of transcriptional and translational control in mTOR response. Translation 1: 18-24.
38. Francois-Newton V, Livingstone M, Payelle-Brogard B, Uze G, Pellegrini S (2012) USP18 establishes the transcriptional and anti-proliferative interferon alpha/beta differential. Biochem J 446: 509-516. doi: 10.1042/BJ20120541 PMID: 22731491
39. Marijanovic Z, Ragimbeau J, van der Heyden J, Uze G, Pellegrini S (2007) Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem J 407: 141-151. PMID: 17627610
40. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33: e175. PMID: 16284200
41. Sandberg R, Larsson O (2007) Improved precision and accuracy for microarrays using updated probe set definitions. BMC Bioinformatics 8: 48. PMID: 17288599
42. Colman H, Le Berre-Scoul C, Hernandez C, Pierredon S, Bihouee A, Houlgatte R, et al. (2013) Genome-wide analysis of host mRNA translation during hepatitis C virus infection. J Virol 87: 6668-6677. doi: 10.1128/JVI.00538-13 PMID: 23552407
43. Larsson O, Sonenberg N, Nadon R (2010) Identification of differential translation in genome wide studies. Proc Natl Acad Sci USA 107: 21487-21492. doi: 10.1073/pnas.1006821107 PMID: 21115840
44. Larsson O, Sonenberg N, Nadon R (2011) anota: Analysis of differential translation in genome-wide studies. Bioinformatics 27: 1440-1441. doi: 10.1093/bioinformatics/btr146 PMID: 21422072
45. Wright GW, Simon RM (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 2448-2455. PMID: 14668230
46. Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, et al. (2008) Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118: 3065-3074. doi: 10.1172/JCI34739 PMID: 18725988
47. Wang X, Hawk N, Yue P, Kauh J, Ramalingam SS, Fu H, et al. (2008) Overcoming mTOR inhibitioninduced paradoxical activation of survival signaling pathways enhances mTOR inhibitors' anticancer efficacy. Cancer Biol Ther 7: 1952-1958. PMID: 18981735
48. Feldman ME, Apsel B, Uotila A, Loewith R, Knight ZA, Ruggero D, et al. (2009) Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 7: e38. doi: 10.1371/ journal.pbio.1000038 PMID: 19209957
49. Larsson O, Tian B, Sonenberg N (2013) Toward a genome-wide landscape of translational control. Cold Spring Harb Perspect Biol 5: a012302. doi: 10.1101/cshperspect.a012302 PMID: 23209130
50. Piccirillo CA, Bjur E, Topisirovic I, Sonenberg N, Larsson O (2014) Translational control of immune responses: from transcripts to translatomes. Nat Immunol 15: 503-511. doi: 10.1038/ni.2891 PMID: 24840981
51. Tang H, Hornstein E, Stolovich M, Levy G, Livingstone M, Templeton D, et al. (2001) Amino acidinduced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol 21: 8671-8683. PMID: 11713299
52. Maruyama K, Sugano S (1994) Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene 138: 171-174. PMID: 8125298
53. Samarajiwa SA, Forster S, Auchettl K, Hertzog PJ (2009) INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res 37: D852-857. doi: 10.1093/nar/gkn732 PMID: 18996892
54. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, et al. (2007) Evidence based selection of housekeeping genes. PLoS ONE 2: e898. PMID: 17878933
55. Aksoy P, Zhu MJ, Kalari KR, Moon I, Pelleymounter LL, Eckloff BW, et al. (2009) Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics. Pharmacogenetics and genomics 19: 567-576. doi: 10.1097/FPC.0b013e32832c14b8 PMID: 19623099
56. Rich SA, Bose M, Tempst P, Rudofsky UH (1996) Purification, microsequencing, and immunolocalization of p36, a new interferon-alpha-induced protein that is associated with human lupus inclusions. J Biol Chem 271: 1118-1126. PMID: 8557639
57. Kaur S, Sassano A, Dolniak B, Joshi S, Majchrzak-Kita B, Baker DP, et al. (2008) Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci USA 105: 4808-4813. doi: 10.1073/pnas.0710907105 PMID: 18339807
58. Forrest AR, Kawaji H, Rehli M, Baillie JK, de Hoon MJ, Haberle V, et al. (2014) A promoter-level mammalian expression atlas. Nature 507: 462-470. doi: 10.1038/nature13182 PMID: 24670764
59. Schmeisser H, Bekisz J, Zoon KC (2014) New function of type I IFN: induction of autophagy. J Interferon Cytokine Research 34: 71-78.
60. Schmeisser H, Fey SB, Horowitz J, Fischer ER, Balinsky CA, Miyake K, et al. (2013) Type I interferons induce autophagy in certain human cancer cell lines. Autophagy 9: 683-696. doi: 10.4161/auto.23921 PMID: 23419269
61. Francois-Newton V, Magno de Freitas Almeida G, Payelle-Brogard B, Monneron D, Pichard-Garcia L, Piehler J, et al. (2011) USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response. PLoS ONE 6: e22200. doi: 10.1371/journal. pone.0022200 PMID: 21779393
62. Rastogi R, Jiang Z, Ahmad N, Rosati R, Liu Y, Beuret L, et al. (2013) Rapamycin induces mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) expression through activation of protein kinase B and mitogen-activated protein kinase kinase pathways. J Biol Chem 288: 33966-33977. doi: 10.1074/ jbc.M113.492702 PMID: 24126911
63. Zhao J, Benakanakere MR, Hosur KB, Galicia JC, Martin M, Kinane DF (2010) Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes. Mol Immunol 48: 294-304. doi: 10.1016/j.molimm.2010.07.014 PMID: 20728939
64. Rees DC, Duley JA, Marinaki AM (2003) Pyrimidine 5' nucleotidase deficiency. Br J Haematol 120: 375-383. PMID: 12580951 64. Rees DC, Duley JA, Marinaki AM (2003) Pyrimidine 5' nucleotidase deficiency. Br J Haematol 120: 375-383. PMID: 12580951
65. Kaur S, Kroczynska B, Sharma B, Sassano A, Arslan AD, Majchrzak-Kita B, et al. (2014) Critical roles for Rictor/Sin1 complexes in IFN-dependent gene transcription and generation of antiproliferative responses. J Biol Chem 289: 6581-6591. doi: 10.1074/jbc.M113.537852 PMID: 24469448